XNM-1011

N/A

Report date: 2022/04/26 17:54:38
NME

Base Information

Drug NameXNM-1011
Drug Alias NameXNM-1011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitors
TargetsTyrosine-protein kinase BTK
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesSinolink Pharma (Suzhou) Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSinolink Pharma (Suzhou) Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A